SHPMY:OTCMKTS
Shanghai Pharmaceuticals Holdings ADR
$7.08
0.00%
(0.00) 1 日
10月1日, 14:50:24 GMT-4 · USD
search
すべての記号
| 記号 | 価格 | 変化 | 変化率 |
|---|
insights_autoSHPMY の上位の分析情報を生成しています...
時価総額
645.54億
平均出来高
116.00
取引量
0.00
52 週高値
$8.23
52 週安値
$6.41
ベータ版
0.58
発行済株式数
1.84億
従業員数
5万
時価総額
645.54億
平均出来高
116.00
取引量
0.00
52 週高値
$8.23
52 週安値
$6.41
ベータ版
0.58
発行済株式数
1.84億
従業員数
5万
ニュース記事
情報源: ウェブソース、ニュース パートナー
みんかぶ FX/為替
·
1 日前
ＮＹ各市場 ４時台 ダウ平均は５１２ドル高 シカゴ日経平均先物は６万９１００円
TradingKey
·
2 日前
ダウが400ポイント超上昇し米国株高；ハイテクと製薬が牽引；パランティアは5%急伸し最高値更新
BigGo ファイナンス
·
1 日前
株式市場のバリュエーションをめぐる混乱しがちな真実｜The Plain Bagel
プロフィール
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
Shanghai Pharmaceuticals Holdings ADR について